groups. In the second phase of the program, 10 neighorhoods were added to the home visiting program, and 8 were added to the center-based program. In the final phase of the program, the remaining 10 control
Research to Tackle Diseases of Poverty Socinstrasse 57, 4051 Basel IBAN: CH92 0076 9039 7436 5200 8 More information on www.geigystiftung.ch If you would like to support our research, please do not hesitate
around USD 283 billion in total gross domestic product (GDP) – a benefit to cost ratio in excess of 8:1. About the WHO's Strategic Advisory Group on Eradication (SAGme) SAGme is composed of 13 leaders and
can I contact if I have questions? If you have any questions, you can contact us by telephone (Mo–Fr, 8:00–17:00), WhatsApp or email (languages: German, English). Contacting us is non-binding. Phone/WhatsApp: [...] PhD, MSc Study Assistant: Fiona Streit, MSc ETH Contact: Phone, WhatsApp: +41 79 840 76 56 (Mo–Fr, 8:00–17:00) Email: markopolo @ swisstph.ch Contacting us is non-binding.
in sub-Saharan Africa. Against this background, the Multilateral Initiative on Malaria (MIM Society) 8th Pan-African Malaria Conference is currently taking place in Kigali, Rwanda. Coinciding with this years’ [...] malaria community for the first time in six years. The Multilateral Initiative on Malaria (MIM Society) 8th Pan-African Malaria Conference (PAMC) is taking place in Kigali, Rwanda, gathers 1,500 policy-makers
in low-income settings and the combination therapy requires daily visits in health centres over an 8-week period. More importantly, the antibiotics result in severe adverse side effects with over 20% of [...] the treatment of Buruli ulcer. (2018) Nature Communications. https://doi.org/10.1038/s41467-018-07804-8
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188... (Publications)
to 71.5 years (71.0-71.9) in 2013, HALE at birth rose by 5.4 years (4.9-5.8), from 56.9 years (54.5-59.1) to 62.3 years (59.7-64.8), total DALYs fell by 3.6% (0.3-7.4), and age-standardised DALY rates per
Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled,... (Publications)
glycoprotein peaked on day 28 at 51 mug/mL (95% CI 41.1-63.3) in the high-dose group, 44.9 mug/mL (25.8-56.3) in the low-dose group, and 5.2 mug/mL (3.5-7.6) in the placebo group, with respective response [...] developed glycoprotein-specific CD4 cell responses, and 33 (67%) and 35 (69%), respectively, developed CD8 responses. INTERPRETATION: ChAd3-EBO-Z was safe and well tolerated, although mild to moderate systemic
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188... (Publications)
to 71.5 years (71.0-71.9) in 2013, HALE at birth rose by 5.4 years (4.9-5.8), from 56.9 years (54.5-59.1) to 62.3 years (59.7-64.8), total DALYs fell by 3.6% (0.3-7.4), and age-standardised DALY rates per
Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled,... (Publications)
glycoprotein peaked on day 28 at 51 mug/mL (95% CI 41.1-63.3) in the high-dose group, 44.9 mug/mL (25.8-56.3) in the low-dose group, and 5.2 mug/mL (3.5-7.6) in the placebo group, with respective response [...] developed glycoprotein-specific CD4 cell responses, and 33 (67%) and 35 (69%), respectively, developed CD8 responses. INTERPRETATION: ChAd3-EBO-Z was safe and well tolerated, although mild to moderate systemic
